Related Experiment Video

Updated: Dec 13, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.1K

Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway

B-Q Wu1, Y Cao, Z-G Bi

  • 1Department of Orthopedics, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

European Review for Medical and Pharmacological Sciences
|August 4, 2020
PubMed

Insights

This article on adriamycin resistance in osteosarcoma has been withdrawn due to suspected research misconduct. The publisher retracted the study after authors failed to verify data originality.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Adriamycin resistance is a significant challenge in osteosarcoma treatment.
  • The Wnt/β-catenin signaling pathway is implicated in various cancers, including osteosarcoma.

Purpose of the Study:

  • To investigate the potential of blocking the Wnt/β-catenin signal pathway to suppress adriamycin resistance in osteosarcoma.

Main Methods:

  • The study aimed to explore the molecular mechanisms underlying adriamycin resistance.
  • Investigated the role of the Wnt/β-catenin pathway in modulating drug resistance.

Main Results:

  • The article reported that suppressing the Wnt/β-catenin pathway could inhibit adriamycin resistance in osteosarcoma.
  • Specific molecular targets and pathways were discussed in relation to this effect.

Conclusions:

  • The findings suggested a potential therapeutic strategy for overcoming adriamycin resistance in osteosarcoma.
  • Blocking the Wnt/β-catenin pathway was proposed as a method to enhance chemotherapy efficacy.

More Related Videos

The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

113.3K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.8K

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.1K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.9K